CAFs contribute to tumor progression through angiogenesis by releasing VEGF and CXCL-12, invasion, metastasis, immune suppression by recruiting immunosuppressive cells, and therapy resistance through recruitment of cytokines[57]. This evidence concerns the gene VEGFA and neoplasm.